GNRH family genes contributed to gender-specific disparity of bladder cancer prognosis through exerting opposite regulatory roles between males and females-Reference-Cited by-同舟云学术

GNRH family genes contributed to gender-specific disparity of bladder cancer prognosis through exerting opposite regulatory roles between males and females

Published:2023-02-19 Issue:10 Volume:149 Page:6827-6840
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Song Yuxuan,Qin Caipeng,Zhang Chunlong,Peng Yun,Yang Wenbo,Du Yiqing,Xu Tao

Funder

Capital's Funds for Health Improvement and Research

National Key Research and Development Program of China

Natural Science Foundation of Beijing Municipality

National Natural Science Foundation of China

Beijing Municipal Science and Technology Commission

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-04640-2.pdf

Reference41 articles.

1. Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F (2017) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71(1):96–108

2. Boorjian S, Ugras S, Mongan NP, Gudas LJ, You X, Tickoo SK, Scherr DS (2004) Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer. Urology 64(2):383–388

3. Cohn JA, Vekhter B, Lyttle C, Steinberg GD, Large MC (2014) Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation. Cancer 120(4):555–561

4. Dobruch J, Daneshmand S, Fisch M, Lotan Y, Noon AP, Resnick MJ, Shariat SF, Zlotta AR, Boorjian SA (2016) Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes. Eur Urol 69(2):300–310

5. Ebrahimi H, Amini E, Pishgar F, Moghaddam SS, Nabavizadeh B, Rostamabadi Y, Aminorroaya A, Fitzmaurice C, Farzadfar F, Nowroozi MR, Black PC, Daneshmand S (2019) Global, regional and national burden of bladder cancer, 1990 to 2016: results from the GBD Study 2016. J Urol 201(5):893–901

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gender difference of bladder cancer: insights from hormone, anatomy and tumor microenvironment;World Journal of Urology;2024-07-10

2. Role of gonadotropin-releasing hormone 2 and its receptor in human reproductive cancers;Frontiers in Endocrinology;2024-01-08

3. Three versus four cycles of neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and meta-analysis;Annals of Medicine;2023-11-14

4. Letter to the editor for the article “5-alpha reductase inhibitors (5-ARi) with or without alpha-blockers (α-B) for Benign Prostatic Hyperplasia do NOT lower the risk of incident Bladder Cancer: United States insurance claims data”;World Journal of Urology;2023-09-12

5. Letter to the editor for the article “Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes”;World Journal of Urology;2023-09-05